Patents by Inventor Richard G. Nause

Richard G. Nause has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE FORMS OF APIXABAN
    Publication number: 20170202826
    Abstract: The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for preventing or treating venous thromboembolisms, deep vein thrombosis and acute coronary syndrome with said dosage form.
    Type: Application
    Filed: March 30, 2017
    Publication date: July 20, 2017
    Inventor: Richard G. Nause
  • DOSAGE FORMS OF APIXABAN
    Publication number: 20140335178
    Abstract: The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for preventing or treating venous thromboembolisms, deep vein thrombosis and acute coronary syndrome with said dosage form.
    Type: Application
    Filed: May 19, 2014
    Publication date: November 13, 2014
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, PFIZER INC.
    Inventor: Richard G. Nause
  • DOSAGE FORMS OF APIXABAN
    Publication number: 20140030330
    Abstract: The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for preventing or treating venous thromboembolisms, deep vein thrombosis and acute coronary syndrome with said dosage form.
    Type: Application
    Filed: July 2, 2013
    Publication date: January 30, 2014
    Inventor: Richard G. Nause
  • DOSAGE FORMS OF APIXABAN
    Publication number: 20120087978
    Abstract: The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for preventing or treating venous thromboembolisms, deep vein thrombosis and acute coronary syndrome with said dosage form.
    Type: Application
    Filed: June 15, 2010
    Publication date: April 12, 2012
    Applicants: BRISTOL-MYERS SQUIBB COMPANY, PFIZER INC.
    Inventor: Richard G. Nause